Cancer Advocacy | Biomarker Testing | Bladder Cancer, Cancer Information Highlights, 03/17/2021

National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
New from NCI
How a Cancer Advocate Goes the Distance for Underserved Communities
NCA50, Nothing Will Stop Us   Access to remote communities is a challenge, but talking about cancer is more difficult. Read about Phyllis Pettit Nassi's story as a cancer advocate and her efforts to improve access to care for underserved communities.
Biomarker Testing for Cancer Treatment
doctor and patient look at a tablet together   Biomarker testing is a way to look for genes, proteins, and other substances in a sample of cancer cells that can provide information about that cancer. Learn how biomarker testing may help you and your doctor choose a cancer treatment for you.
Pandemic Creates Problems and Opportunities for Cancer Screening
person lying on a table ready to go into an MRI machine   After a steep drop in screening for common cancers early in the COVID-19 pandemic, researchers are exploring ways to improve cancer screening during the current crisis and beyond.
Advances in Bladder Cancer Research

Researchers are working to improve our understanding of how to treat bladder cancer. With recent advances in immunotherapy and targeted therapy, treatment for this cancer has the potential to become more effective and less toxic.
Imaging Test Could Help Guide Breast Cancer Treatment Decisions

A new NCI-funded study shows that for some people with ER-positive breast cancer, a new imaging test may help guide decisions about receiving hormone therapy. The test can show whether estrogen receptors in tumors are active and responding to estrogen.
Remembering Cancer Research Greats
Dr. Emil Freireich working with a blood cell separator   Following the death of Dr. Emil Freireich in February, NCI Director Dr. Norman E. Sharpless reflects on the achievements and legacies of Dr. Freireich and several other cancer research pioneers who have passed in recent years.
Test Could Help Decide Who Should Get Hormone Therapy for Prostate Cancer

For some people with prostate cancer, a biomarker test called Decipher may help predict if their cancer will spread elsewhere in the body. The test could help them decide whether hormone therapy, which can cause distressing side effects, is needed.
Hormone Therapy for Prostate Cancer

We’ve updated our page describing hormone therapy and its role in treating prostate cancer. Learn about the types of hormone therapy, how they are used, and possible side effects.

FDA Approvals
New Treatment for Lung Cancer

We’ve added a new drug summary for tepotinib hydrochloride (Tepmetko), which the Food and Drug Administration (FDA) recently approved to treat adults with metastatic non-small cell lung cancer that has a certain mutation in the MET gene.
CAR T-Cell Therapy for Follicular Lymphoma

We’ve updated our drug summary for axicabtagene ciloleucel (Yescarta), a type of CAR T-cell therapy, to include a recent FDA approval for follicular lymphoma.
Also of Interest
Nutrition for People with Cancer

March is National Nutrition Month. Two NCI resources, Eating Hints: Before, during, and after Cancer Treatment and Nutrition in Cancer Care, describe eating problems caused by cancer and contain tips for managing these problems.
Contact Us for Help

Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.